HRS 2020: Primary Outcome Evaluation of The PINNACLE FLX Study

Published: 25 May 2020

  • Views:

    Views Icon 253
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA, US) discusses the results from the PINNACLE FLX Study. 
The PINNACLE FLX Study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation therapy to reduce the risk of stroke but who have a rationale to seek a non-pharmacologic alternative.


1. Can you describe the technology used in this study and how it differs from previous models?
2. What was the design and endpoints of this study?
3. What were your findings?
4. Which patients should be considered for this device?
5. What further research will be conducted?


Recording Editor: Natascha Wienand
Interviewer: Mirjam Boros